NOVOZYMES A/S: Financial statements 2023
CVR: 10007127
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
NOVOZYMES A/S (CVR 10007127) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 17,899,000,000 and a net result of DKK 3,039,000,000 compared with DKK 3,686,000,000 the year before. That is an increase of 2% compared with the year before. The profit margin was 17%. Equity in the 2023 report amounted to DKK 14,351,000,000. The solvency ratio was 50.5%. The company had 6,805 employees in the financial year.
- Revenue
- DKK 17,899,000,000
- Gross Profit
- DKK 9,722,000,000
- Profit/Loss
- DKK 3,039,000,000
- Equity
- DKK 14,351,000,000
- Total Assets
- DKK 28,391,000,000
- Employees
- 6,805
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 17.9B | 9.7B | 3B | 14.4B | 6805 |
| 2022 | 17.6B | 9.6B | 3.7B | 14.2B | 6690 |
| 2021 | 15B | 8.6B | 3.1B | 12.2B | 6240 |
| 2020 | 14B | 7.9B | 2.8B | 11.2B | 6099 |
| 2019 | 14.4B | 8B | 3.2B | 11.5B | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 1, 2023, Rainer Chapour Lehmann is registered as director of NOVOZYMES A/S.
As of November 1, 2023, Lars Green has stepped down as director of NOVOZYMES A/S.
NOVOZYMES A/S has published its interim report for the period January 1, 2023 to September 30, 2023.
NOVOZYMES A/S has published its interim report for the period January 1, 2023 to June 30, 2023.
NOVOZYMES A/S has published its interim report for the period January 1, 2023 to March 31, 2023.
NOVOZYMES A/S has published its annual report for 2022. Revenue came to DKK 17,553,000,000, and the net result was DKK 3,686,000,000.
As of March 2, 2023, Kim Narelle Stratton has joined the board of directors of NOVOZYMES A/S.
As of March 2, 2023, Cornelis de Jong has joined the board of directors of NOVOZYMES A/S.
As of March 2, 2023, Jørgen Buhl Rasmussen has left the board of directors of NOVOZYMES A/S.
As of March 1, 2023, Kim Narelle Stratton has left the board of directors of NOVOZYMES A/S.
About NOVOZYMES A/S
NOVOZYMES A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2000. The company is registered under the industry Fremstilling af andre organiske basiskemikalier. The management consists of Ester Baiget Arnau and Rainer Chapour Lehmann. The board consists of Cornelis de Jong (chair), Heine Dalsgaard, Frederikke Rose Spenner and Kasim Kutay. The company is owned by Novo Holdings A/S and BlackRock, Inc.. The company has 3,508 employees (2026). In 2025, the company reported revenue of EUR 4,157,600,000 and a net result of EUR 583,600,000 compared with EUR 305,800,000 the year before. Equity in the 2025 report amounted to EUR 10,855,200,000.